How to balance growth and income when investing
Dividend-paying stocks have beaten the market. That doesn’t mean that income funds will do best
Income has historically been one of the best-performing investment strategies. The average annualised return of dividend-paying stocks in the S&P 500 between 1973 and 2024 was 9.2%, compared with 4.3% for non-dividend-paying stocks, according to a study by Ned Davis Research. What’s more, dividend payers were less volatile and offered more protection during market downturns. In 2022, when the S&P 500 declined by more than 18%, dividend-paying stocks in the index fell by 11.1%, while non-dividend payers experienced a 38.7% loss. In the global financial crisis of 2007-2009, S&P 500 earnings per share plummeted by 92% while dividends fell by only 6%.
A wealth of other studies come to a similar conclusion. One explanation for this is superior financial health. Companies with the best dividend records tend to have robust balance sheets, strong profit margins and substantial economies of scale, as well as competitive advantages. Cash that isn’t distributed is reinvested, used to reduce debt or spent on buying back stock.
Avoid the income trap
However, investors need to be careful what lessons they take from this. Companies outperform not because they pay a dividend, but because they are financially responsible enough to maintain that dividend. Do not confuse yield with value or quality. A company that offers a high dividend yield is not necessarily cheap or a good business. In fact, the very highest-yielding stocks often underperform the market over time – their dividends are high because they are unsustainable. Some research suggests splitting the market into five groups by yield and focusing on the second-highest yielding group instead.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Income investors and fund managers chasing yield often fall into these kinds of traps. Active fund managers with an income mandate are particularly vulnerable, since they must keep pace with the rest of the industry.
The FTSE 100 currently yields roughly 4%, and many UK equity income managers will use this as a benchmark for their portfolio. That means they could be forced to deploy capital in stocks that are not necessarily of the best quality but offer the highest yields, in order to maintain the yield from their fund.
Balance income and growth
Instead of relying solely on the dividend yield, investors should consider funds that take into account the total shareholder return, also known as the total shareholder yield. Companies that return cash to shareholders through other methods – such as stock buybacks or debt repayment – have more flexibility than firms trying to chase fixed dividend targets.
Management can switch off buybacks at any point, and often pause paying down many types of debt if they wish. Reneging on dividend expectations is significantly more risky. There’s a lengthy list of CEOs who have had to step down after U-turning on a dividend commitment.
Investors should also look at growth. Dividends are powerful, but a company’s earnings growth ultimately dictates how much cash it can return to investors. A fund that focuses on growth rather than income could generate better long-term returns.
You can still draw a regular income from a fund that achieves strong capital gains by selling, say, 4% of your holding every year. Since the top rate of capital gains tax is currently 28%, compared with 39.4% for dividends, there may be a tax benefit to this approach as well, if your fund is held outside a tax wrapper such as an individual savings account (ISA).
JPMorgan Global Growth and Income (LSE: JGGI) is one such fund we like. Passive investors might look at an exchange-traded fund (ETF) such as Fidelity Global Quality Income ETF (LSE: FGQD).
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.

Rupert is the former deputy digital editor of MoneyWeek. He's an active investor and has always been fascinated by the world of business and investing. His style has been heavily influenced by US investors Warren Buffett and Philip Carret. He is always looking for high-quality growth opportunities trading at a reasonable price, preferring cash generative businesses with strong balance sheets over blue-sky growth stocks.
Rupert has written for many UK and international publications including the Motley Fool, Gurufocus and ValueWalk, aimed at a range of readers; from the first timers to experienced high-net-worth individuals. Rupert has also founded and managed several businesses, including the New York-based hedge fund newsletter, Hidden Value Stocks. He has written over 20 ebooks and appeared as an expert commentator on the BBC World Service.
-
Can the gold price rise to $6,000?Gold prices have made dramatic jumps early in 2026. Can gold keep rising, or is it becoming a victim of its own success?
-
The coastal locations where properties are losing valueProperty prices across a number of coastal hotspots plunged in 2025 - which areas are most affected?
-
Three promising emerging-market stocks to diversify your portfolioOpinion Omar Negyal, portfolio manager, JPMorgan Global Emerging Markets Income Trust, highlights three emerging-market stocks where he’d put his money
-
Coface offers excess profit in an unloved sectorCoface is a world leader in trade-credit insurance with key competitive advantages in a niche market
-
Exciting opportunities in biotechBiotech firms should profit from the ‘patent cliff’, which will force big pharmaceutical companies to innovate or make acquisitions
-
Profit from pest control with Rentokil InitialRentokil Initial is set for global expansion and offers strong sales growth
-
Three funds to buy for capital growth and global incomeOpinion Three investment trusts with potential for capital growth, selected by Adam Norris, co-portfolio manager of the CT Global Managed Portfolio Trust
-
PayPoint: a promising stock for income-seekersPayPoint, a household name across Britain, is moving away from its traditional roots toward a digital future. Investors after a steady income should buy in
-
Investing in forestry: a tax-efficient way to grow your wealthRecord sums are pouring into forestry funds. It makes sense to join the rush, says David Prosser
-
The MoneyWeek investment trust portfolio – early 2026 updateThe MoneyWeek investment trust portfolio had a solid year in 2025. Scottish Mortgage and Law Debenture were the star performers, with very different strategies